Nearly all the world’s 10.6 million children experiencing serious health-related suffering (SHS) live in low- and middle-income countries with little to no access to palliative care specialized care for their illness, according to a comprehensive new report published in The Lancet Child & Adolescent Health. The study defines SHS as physical, psychological, social or spiritual … Read more
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage of patients successfully completed both regimens and suffered few adverse side effects. A team led by Richard Chaisson, of the Johns Hopkins School of Medicine, U.S.A., reports these findings February 10th in the open access journal PLOS Medicine. … Read more
Health-economic analysis evaluates TB infection screening strategies among people living with HIV in Thailand February 9, 2026 | Monday | News Analysis modeled one-time TB infection screening in adults living with HIV A study was recently conducted to support evidence-based decision making in Thailand and to help policymakers in low and middle income countries evaluate … Read more
Sepsis is a leading global cause of hospital deaths, occurring when the body’s response to infection damages tissue and causes organs to fail. Africa bears the world’s highest burden of sepsis, with an estimated 48 million cases each year leading to about 11 million deaths. People living with HIV face the greatest risk of dying … Read more
Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are diagnosed with TB – could save countless lives, the researchers say. The ATLAS study, conducted over five years at hospitals in Tanzania and … Read more
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game changer for preventing HIV and for treating multidrug-resistant HIV, where it’s used in combination with other antiretrovirals. The drug targets the HIV-1 capsid protein and inhibits viral replication.
A study of almost 1000 pregnant women in Zimbabwe found that a daily dose of a commonly used, safe and inexpensive antibiotic may have led to fewer babies being born early. Among women living with HIV, those who received the antibiotic had larger babies who were less likely to be preterm. One in four live-born … Read more
For years, public health experts have encouraged primary care physicians (PCPs) to screen for infectious diseases as well as cancers, heart disease risk factors, diabetes, and more. Many assessments for risk-based infections such as hepatitis B (Hep B), hepatitis C (Hep C), HIV, and bacterial sexually transmitted infections (STIs) were convoluted and constantly changing, resulting … Read more
TOPLINE: Nearly 12% of individuals using preexposure prophylaxis (PrEP) for HIV prevention, were diagnosed with alcohol use disorder (AUD) within 6 months of initiating PrEP, whereas nearly 3% were diagnosed before initiation. Fewer than 9% of those diagnosed received any US Food and Drug Administration (FDA)–approved medication for AUD. METHODOLOGY: Researchers carried out a retrospective … Read more
Historically, the presence of HIV infection in a patient with end-stage organ failure has been considered an absolute contraindication for organ transplantation. However, advances in antiretroviral therapy have significantly improved life expectancy for people living with HIV to the extent that the condition is now generally managed as a chronic disease. At the same time, … Read more